Relatlimab with nivolumab: Injection concentrate for I.V. infusion containing 80 mg relatlimab and 240 mg nivolumab in 20 mL; Opdualag®
Page last updated: 11 November 2022
Page last updated: 11 November 2022
© Commonwealth of Australia
ABN: 83 605 426 759